Drug Development

News

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio 

Under the deal, Mariana will receive $1bn and up to $750m in additional milestone payments from Novartis.

Jenna Philpott
close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close